We first identified LIMK1 as a top overexpressed gene in gastric cancer peritoneal metastasis, examined its functional role in metastatic progression and demonstrated the therapeutic value of targeting LIMK1 in inhibiting gastric cancer peritoneal metastasis. The gene discussed is LIMK1; the disease is gastric cancer.